Artists from across the country are preparing to head to Wheeling for one of the region’s largest ceramic events, with four days of workshops, exhibitions, demo ...
Q4 2025 earnings call recap: sales, EBITDA and record free cash flow, plus 2026 outlook on cost cuts, pricing, AI and debt.
Klaviyo Inc. (NYSE:KVYO) is one of the best growth stocks to buy for the next 20 years. On February 11, Needham analyst Scott ...
Wall Street forecasts earnings of $0.16 per share on revenue of $988 million, representing a 36% year-over-year decline in profit but a 73% surge in sales. The revenue jump reflects the addition of ...
Asianet Newsable on MSN
Figma Q4 results beat street expectations, so why are analysts slashing targets?
RBC Capital lowered its target on Figma to $31 from $38 and kept a ‘Sector Perform’ rating on the shares, according to TheFly ...
The Hain Celestial Group, Inc. (NASDAQ:HAIN) is one of the best natural and organic food stocks to buy now. On February 17, Stephens adjusted the price target on The Hain Celestial Group, Inc. (NASDAQ ...
Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical-stage biopharmaceutical company focused on ...
Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical-stage biopharmaceutical company focused on developing multimodal biological immunotherapies to help patients fight cancer, ...
The post Canadian Analyst Updates: February 19th, 2026 appeared first on Stock Target Advisor.
Investor's Business Daily on MSN
IPO stock jumps past buy point on booming preliminary revenue, outlook
The company gave preliminary 2025 results and issued its current-year outlook.
The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $370.75, a high ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results